title: Efficacy and safety of levetiracetam in pediatric epilepsy.
abstract: OBJECTIVE
  To evaluate the efficacy and tolerability of Levetiracetam (LEV) as an adjunctive therapy in pediatric patients with different generalized epilepsies.
  
  
  METHODS
  Chart review of 22 consecutive children age 4-19 years who were treated with LEV for at least 1 year was observed retrospectively. The mean dose rang of LEV was from 250 to 2000 mg. Data were collected on epilepsy type, seizure frequency, concomitant antiepileptic drug and adverse effect.
  
  
  RESULTS
  Of the 22 patient reviewed, 13 (59%) were boys and 9 (41%) were girls. Predominant seizure types were generalized tonic-clonic seizures 13 (59%) and tonic seizure 6 (27%). Other seizure types included myoclonic seizures 2 (9%) and focal seizure 3 (5%). The results showed 10 (45%) had become free of seizure for almost 7 months to 1 year. Eight of these 10 patients (80%) had normalized EEG. Seizure frequency was reduced in 9 (41%) patients and 3 (14%) patients still had seizure. No side effects were reported related to LEV treated patients except for 1 patient.
  
  
  CONCLUSIONS
  Our results confirm that LEV may be an effective adjunctive therapy in treatment of childhood epilepsy, especially tonic-clonic seizure, with possible no evident side effect.
authors: Department of Clinical Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia ; Department of Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
authors: Ahmed A
authors: AA
authors: Elberry
authors: Rawabi K
authors: RK
authors: Felemban
authors: Rawan H
authors: RH
authors: Hareeri
authors: Sawsan M
authors: SM
authors: Kurdi
keywords: Epilepsy; Levetiracetam; Pediatric; Seizure
references: Epilepsia. 2002 May;43(5):518-24
references: 12027913
references: Dev Med Child Neurol. 2008 Jan;50(1):29-32
references: 18173626
references: Epilepsy Res. 2006 Jun;69(3):273-94
references: 16621450
references: Neurology. 2004 Feb 24;62(4):640-3
references: 14981187
references: J Child Neurol. 2002 Jun;17(6):413-5
references: 12174960
references: Epilepsia. 2000 Sep;41(9):1179-86
references: 10999557
references: Epilepsia. 2000 Oct;41(10):1276-83
references: 11051122
references: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9861-6
references: 15210974
references: Eur J Pharmacol. 1998 Jul 24;353(2-3):191-206
references: 9726649
references: Eur J Paediatr Neurol. 2003;7(3):123-8
references: 12788038
references: Epilepsia. 2008 Apr;49(4):663-9
references: 18266754
references: Neuropsychiatr Dis Treat. 2008 Jun;4(3):507-23
references: 18830435
references: Epilepsy Behav. 2010 May;18(1-2):100-5
references: 20462804
references: J Child Neurol. 2004 Dec;19(12):944-7
references: 15704867
references: Seizure. 2011 Sep;20(7):554-7
references: 21531583
references: Epilepsia. 2007 Jun;48(6):1123-7
references: 17430408
references: Bull World Health Organ. 2001;79(4):344-51
references: 11357214
references: Epilepsy Behav. 2008 Oct;13(3):557-9
references: 18647662
references: Expert Opin Drug Saf. 2007 May;6(3):241-50
references: 17480174